Search results
Showing: 10 of 670
Opioid Prescribing Comparators dashboard
Opioid prescribing comparators have been developed as part of the work started in response to the Public Health England (PHE) prescribed medicines review.
This dashboard is still a work in progress so we’re working to add more content to help NHS…
Real Time Exemption Checking data
Real Time Exemption Checking (RTEC) is designed to streamline the process for patients and pharmacy teams by improving how exemption categories are recorded.
The NHSBSA reporting of RTEC exemptions has been restricted due to system supplier issues…
Medicines optimisation - generic prescribing
In England, 81% of all drugs in primary care are already prescribed generically, generating significant savings for the NHS.
Building on what’s been achieved with generic prescribing in recent years, we have developed a dashboard providing rapid…
Registering for ePACT2
The ePACT2 system is available only to those users who have registered to access.
Prospective users must choose the relevant access required from the selection available below. It is important that users read the information and requirements before…
Remuneration report
Access for registered users through ePACT2.
The report:
provides information to support the monitoring and management of remuneration payments for pharmaceutical services supplied by pharmacy and appliance contractors
only shows payments which…
Services, schemes and payments
Claiming for services provided and taking part in schemes, and information on the payment information available.
Community Pharmacy Quality Payments Scheme
Pharmacy Access Scheme
NHS Urgent Medicines Supply Advanced Service pilot
Medicines Use…
Data release calendar
We provide NHS stakeholders with:
prescribing volume, trend and cost analyses - the analysis is based on prescriptions dispensed in the community by GPs and other prescribers
dental activity and payment analyses - the analyses is based on FP17(O…
ePACT2: Antimicrobial Stewardship – Pharmacy First Dashboard
Combatting antimicrobial resistance, the UK’s second five-year national action plan continues to promote optimal use of antimicrobials in humans to ensure safe and effective patient care by strengthening antimicrobial stewardship programmes. There…